Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 4,702 Jan 1 – Oct 24, 2026
- Disclosed funding
- $299.7B 3666 disclosed amounts
- Median round
- $14.5M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
GoodwallCompany profile A mobile social-learning platform that helps young people build practical skills through short courses, partner challenges and credentials. A mobile social-learning platform that helps young people build practical skills through short courses, partner challenges and credentials. | CHF 400K | FIF Growth awardGrowth | Edtech | Switzerland | Investors | |
| I IztriCompany profile An app-based fabric-care service arranging doorstep collection, ironing, dry cleaning and shoe care for households. An app-based fabric-care service arranging doorstep collection, ironing, dry cleaning and shoe care for households. | Undisclosed | Seed | Consumer | India | Investors | |
| MB Moonwalk BiosciencesCompany profile Moonwalk Biosciences is developing adipose-targeted siRNA medicines for obesity and cardiometabolic disease. Its lead programs are designed to alter fat-tissue pathways while limiting effects on other tissues, with the lead obesity candidate in IND-enabling development ahead of planned human testing in 2027. Moonwalk Biosciences is developing adipose-targeted siRNA medicines for obesity and cardiometabolic disease. Its lead programs are designed to alter fat-tissue pathways while limiting effects on other tissues, with the lead obesity candidate in IND-enabling development ahead of planned human testing in 2027. | $70M | Series B | Biotech | United States | Investors | |
| C CircolifeCompany profile A subscription service providing businesses with connected air conditioners, maintenance and energy-use monitoring. A subscription service providing businesses with connected air conditioners, maintenance and energy-use monitoring. | $4.5M | Pre-Series AUndisclosed | Climate tech | India | Investors | |
SagavaCompany profile A Danish climate-technology startup developing a process that turns biogenic waste into drop-in maritime biofuel, biochar and clean energy. A Danish climate-technology startup developing a process that turns biogenic waste into drop-in maritime biofuel, biochar and clean energy. | €1.3M | Venture House follow-on fundingUndisclosed | Climate tech | Denmark | Investors | |
VC TradeCompany profile VC Trade operates a digital marketplace and transaction platform for institutional debt financing. Banks, issuers, arrangers and investors use it to originate, syndicate and administer instruments such as Schuldschein loans and other private-debt products through connected digital workflows. VC Trade operates a digital marketplace and transaction platform for institutional debt financing. Banks, issuers, arrangers and investors use it to originate, syndicate and administer instruments such as Schuldschein loans and other private-debt products through connected digital workflows. | Undisclosed | Minority equity investmentUndisclosed | Fintech | Germany | Investors | |
| F Fab2Company profile Fab2 develops chipmaking equipment and design software to shorten the path from chip design to fabrication. Fab2 develops chipmaking equipment and design software to shorten the path from chip design to fabrication. | $500M | Series A | Hardware | United States | Investors | |
Infera NeuroCompany profile Develops neural-decoding chips for non-invasive thought-to-speech interfaces. Develops neural-decoding chips for non-invasive thought-to-speech interfaces. | CHF 50K | FIF GrantUndisclosed | Hardware | Switzerland | Investors Undisclosed | |
| AH AX Holdings, Inc.Company profile The parent company of Akiya, which converts vacant Japanese properties into employee housing and premises for care providers. The parent company of Akiya, which converts vacant Japanese properties into employee housing and premises for care providers. | ¥370M | Late Seed (second close)Seed | Proptech | Japan | Investors | |
| BB BrainChild BioCompany profile BrainChild Bio develops CAR T-cell therapies for tumors in the central nervous system, including pediatric brain cancers and glioblastoma. BrainChild Bio develops CAR T-cell therapies for tumors in the central nervous system, including pediatric brain cancers and glioblastoma. | $116M | Series A | Biotech | United States | Investors Undisclosed |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
BioStack, Tractian, Blacksmith
161rounds5led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
111rounds21led - 3General Catalyst
Tractian, Legora, Different
100rounds12led - 4Lightspeed
Warp Sciences, Different, Zenzap
80rounds9led - 5Sequoia Capital
Warhound, Whop, Blacksmith
71rounds13led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →